MedicineMarch 1, 2022
Messenger RNA Therapies Are Finally Fulfilling Their Promise
Instructing our cells to make specific proteins could control influenza, autoimmune diseases, even cancer
Stories by Drew Weissman
Drew Weissman is a professor of vaccine research at the University of Pennsylvania. The nucleoside-modified mRNA-lipid-nanoparticle vaccine platform his laboratory created is used in COVID-19 vaccines made by Pfizer-BioNTech and Moderna. Weissman receives royalties from a patent for nucleoside-modified mRNA that is licensed by those two companies.